Medicalsystem Biotechnology Co., Ltd

Equities

300439

CNE100001Z25

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-29 pm EDT 5-day change 1st Jan Change
10.19 CNY +3.14% Intraday chart for Medicalsystem Biotechnology Co., Ltd +5.05% -12.23%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Medicalsystem Biotechnology Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Medicalsystem Biotechnology Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
MedicalSystem Biotechnology Gets Nod to Market Fibrinogen Detection Kit MT
Medicalsystem Biotechnology Co., Ltd Announces Board Appointments CI
Medicalsystem Biotechnology Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
MedicalSystem Biotechnology Registers Thyroid Protein Detection Kit MT
Medicalsystem Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Ningbo Ruiheyuan Biotechnology Co., Ltd. announced that it expects to receive CNY 192 million in funding from Medicalsystem Biotechnology Co., Ltd CI
Medicalsystem Biotechnology Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 16 June 2023 CI
Medicalsystem Biotechnology Co., Ltd. Approves Cash Dividend for the Year 2022 CI
MedicalSystem Biotechnology Registers Two New Medical Devices MT
Medicalsystem Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Medicalsystem Biotechnology Co., Ltd. Approves Final Dividend for 2022 CI
Medicalsystem Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Chen Chaohong completed the acquisition of a 5% stake in Medicalsystem Biotechnology Co., Ltd. from Zou Bingde. CI
MedicalSystem Biotechnology Registers Two New Medical Devices in China MT
MedicalSystem Biotechnology Registers Two New Medical Devices MT
Chen Chaohong signed the Share Transfer Agreement to acquire 5% stake in Medicalsystem Biotechnology Co., Ltd. from Zou Bingde for approximately CNY 180 million CI
Medicalsystem Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Medicalsystem Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Medicalsystem Biotechnology Co., Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on June 8, 2022 CI
Medicalsystem Biotechnology Co., Ltd. Approves Cash Dividend for 2021 CI
Medicalsystem Biotechnology Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Medicalsystem Biotechnology Co.,Ltd Announces Cash Dividend Proposal for the Year 2021 CI
Medicalsystem Biotechnology Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Chart Medicalsystem Biotechnology Co., Ltd
More charts
MedicalSystem Biotechnology Co., Ltd. is a China-based company engaged in the research and development, manufacture and distribution of in-vitro diagnostic products. The Company’s in-vitro diagnostic products include in-vitro diagnostic reagent and in-vitro diagnostic instrument. In addition, the Company is also involved in the provision of third-party medical diagnosis services, as well as the production and distribution of reagent raw materials. The Company mainly operates businesses in domestic market.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. 300439 Stock
  4. News Medicalsystem Biotechnology Co., Ltd
  5. MedicalSystem Biotechnology Registers Two New Medical Devices